AZIMUTH PHARMA LIMITED

Active Macclesfield

Activities of head offices

0 employees website.com
Activities of head offices
A

AZIMUTH PHARMA LIMITED

Activities of head offices

Founded 19 Jan 2012 Active Macclesfield, England 0 employees website.com
Activities of head offices

Previous Company Names

AZIMUTH MEDICAL LIMITED 19 Jan 2012 — 23 Jan 2012
Accounts Submitted 27 Jun 2025 Next due 30 Jun 2026 2 months remaining
Confirmation Submitted 5 Feb 2026 Next due 6 Feb 2027 9 months remaining
Net assets £456K £0 2024 year on year
Total assets £527K £0 2024 year on year
Total Liabilities £70K £0 2024 year on year
Charges 1
1 outstanding

Contact & Details

Contact

Registered Address

Suite A, Greenway House Larkwood Way Tytherington Business Park Macclesfield SK10 2XR England

Full company profile for AZIMUTH PHARMA LIMITED (07916512), an active company based in Macclesfield, England. Incorporated 19 Jan 2012. Activities of head offices. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2014–2024)

Cash in Bank

N/A

Net Assets

£456.17k

Total Liabilities

£70.47k

Turnover

N/A

Employees

N/A

Debt Ratio

13%

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (1)

Bioscript Limited
100.0%
525

Persons with Significant Control

Persons with Significant Control (1)

1 Active 2 Ceased

Bioscript Limited

United Kingdom

Active
Notified 13 Jul 2021
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Matthew James Stanton

Ceased 7 Nov 2019

Ceased

Graeme David Smith

Ceased 13 Jul 2021

Ceased

Group Structure

Group Structure

BB SHELF 4 LLP united kingdom
BIOSCRIPT LIMITED united kingdom
AZIMUTH PHARMA LIMITED Current Company

Charges

Charges

1 outstanding

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
5 Feb 2026Confirmation StatementConfirmation statement made on 2026-01-23 with no updates
27 Jun 2025AccountsAnnual accounts made up to 2024-09-30
7 Feb 2025OfficersChange to director Mr James Maxwell on 2025-02-06
6 Feb 2025Persons With Significant ControlChange to Bioscript Limited as a person with significant control on 2025-02-06
6 Feb 2025OfficersChange to director Dr Gabrielle Alison Silver on 2025-02-06
5 Feb 2026 Confirmation Statement

Confirmation statement made on 2026-01-23 with no updates

27 Jun 2025 Accounts

Annual accounts made up to 2024-09-30

7 Feb 2025 Officers

Change to director Mr James Maxwell on 2025-02-06

6 Feb 2025 Persons With Significant Control

Change to Bioscript Limited as a person with significant control on 2025-02-06

6 Feb 2025 Officers

Change to director Dr Gabrielle Alison Silver on 2025-02-06

Recent Activity

Latest Activity

Confirmation statement made on 2026-01-23 with no updates

2 months ago on 5 Feb 2026

Annual accounts made up to 2024-09-30

10 months ago on 27 Jun 2025

Change to director Mr James Maxwell on 2025-02-06

1 years ago on 7 Feb 2025

Change to Bioscript Limited as a person with significant control on 2025-02-06

1 years ago on 6 Feb 2025

Change to director Dr Gabrielle Alison Silver on 2025-02-06

1 years ago on 6 Feb 2025